Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$0.75 - $1.29 $29,026 - $49,925
-38,702 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$0.33 - $1.62 $493 - $2,421
-1,495 Reduced 3.72%
38,702 $36,000
Q3 2019

Nov 14, 2019

BUY
$1.25 - $5.0 $34,746 - $138,985
27,797 Added 224.17%
40,197 $88,000
Q2 2019

Aug 15, 2019

BUY
$1.65 - $6.72 $20,460 - $83,328
12,400 New
12,400 $25,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $427M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.